307 related articles for article (PubMed ID: 19462431)
1. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
Sorrentino D; Paviotti A
Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
[No Abstract] [Full Text] [Related]
2. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
Yamamoto T; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
[TBL] [Abstract][Full Text] [Related]
3. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
[TBL] [Abstract][Full Text] [Related]
4. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
5. [Drug therapy of Crohn disease].
Niemelä S
Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
[No Abstract] [Full Text] [Related]
6. Prevention of postoperative recurrence of Crohn's disease.
van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
[TBL] [Abstract][Full Text] [Related]
8. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
Cottone M; Orlando A; Viscido A; Calabrese E; Cammà C; Casà A
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():38-42. PubMed ID: 12786611
[TBL] [Abstract][Full Text] [Related]
9. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
10. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease.
Doherty GA; Miksad RA; Cheifetz AS; Moss AC
Inflamm Bowel Dis; 2012 Sep; 18(9):1608-16. PubMed ID: 21905173
[TBL] [Abstract][Full Text] [Related]
11. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
[TBL] [Abstract][Full Text] [Related]
12. Strategies for the prevention of postoperative recurrence of Crohn's disease.
Yamamoto T; Watanabe T
Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
[TBL] [Abstract][Full Text] [Related]
13. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
14. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
[No Abstract] [Full Text] [Related]
15. [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
Stiefelhagen P
MMW Fortschr Med; 2011 Dec; 153(49-50):20-1. PubMed ID: 22308586
[No Abstract] [Full Text] [Related]
16. Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
Schwartz M; Regueiro M
Curr Gastroenterol Rep; 2011 Feb; 13(1):95-100. PubMed ID: 21042888
[TBL] [Abstract][Full Text] [Related]
17. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Gelber AC
N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20848680
[No Abstract] [Full Text] [Related]
18. A comparison of budesonide and mesalamine for active Crohn's disease.
Lowry PW; Sandborn WJ
Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
[No Abstract] [Full Text] [Related]
19. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?
Kotze PG; Yamamoto T
J Crohns Colitis; 2013 Dec; 7(12):e698. PubMed ID: 23932785
[No Abstract] [Full Text] [Related]
20. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
